Medically reviewed by Susan Bard, MD Psoriasis is a skin condition that causes skin to appear scaly and inflamed. It occurs ...

Discover a recent randomised clinical trial that evaluated the efficacy of a new monoclonal antibody to treat plaque ...

China: A new randomized clinical trial has demonstrated that QX004N, a humanized anti–IL–23 monoclonal antibody, offers ...

For inverse psoriasis, your dermatologist will suggest mild treatment because ... the look of the affected skin. Many of the standard psoriasis treatments work for plaque psoriasis, too, as ...

Plaque psoriasis is the most common type of psoriasis. Plaques are pink/red, raised, thick, inflamed skin patches covered by silvery-white scales. They typically have well-defined edges and may itch.

“I’d always had dry skin from the chlorine in the pool ... who identified her “itchy spots” as evidence of plaque psoriasis, a chronic autoimmune disorder that causes inflammation in ...

“Psoriasis is an inflammatory skin condition that [can cause] very ... the kind in which thick plaques appear is called—fittingly—plaque psoriasis.) These patches can pop up anywhere on ...

Topline results were announced from a phase 3 trial evaluating icotrokinra in patients with moderate to severe plaque psoriasis (PsO ... 0/1 (clear or almost clear skin) with at least a 2 ...

Amgen has won FDA approval for a stronger label for its oral plaque psoriasis ... skin disorder in the US. Crucially, it extends the label for the PDE 4 inhibitor to include people with mild ...

1 Tapinarof cream 1% was previously approved in 2022 to treat adult patients with mild, moderate, and severe plaque psoriasis ...